GlassScriptPhysician profile
Andrew Michael Weber
NPI 1922246982
$19,637.02
in general payments reported to CMS, 2019-2025
90 companies · $2,818 in 2025
The $2,818 reported for 2025 was more than what a typical Hematology (Internal Medicine) provider received nationally (typical 2025 total: $1,177).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,300 · 2020: $2,221 · 2021: $2,827 · 2022: $2,784 · 2023: $3,487 · 2024: $3,201 · 2025: $2,818.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,376 · Education: $130.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,376.16 |
| Education | $129.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,994.99 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,127.53 | 2019-2025 | Imfinzi, Calquence, Enhertu |
| Celgene Corporation | $1,080.07 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| E.R. Squibb & Sons, L.L.C. | $1,044.58 | 2019-2025 | Opdivo, Opdualag, Krazati |
| Janssen Biotech, INC. | $1,013.25 | 2019-2025 | Darzalex, Tecvayli, Talvey |
| Regeneron Healthcare Solutions, INC. | $906.42 | 2020-2025 | Libtayo |
| Merck Sharp & Dohme LLC | $886.62 | 2019-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Amgen INC. | $821.27 | 2019-2023 | Nplate, Vectibix, Xgeva |
| Genzyme Corporation | $652.56 | 2019-2025 | |
| Stemline Therapeutics INC. | $640.49 | 2020-2025 | Elzonris, Orserdu |
| Daiichi Sankyo INC. | $637.32 | 2019-2025 | Enhertu, Datroway, Injectafer |
| Genentech USA, INC. | $495.29 | 2019-2025 | Polivy, Lunsumio, Columvi |
| Eisai INC. | $491.15 | 2019-2025 | |
| Pfizer INC. | $440.01 | 2019-2025 | |
| Ipsen Biopharmaceuticals, INC | $403.27 | 2019-2025 | Onivyde, Somatuline Depot |
Show all 90 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $392.49 | 2019-2025 | Monjuvi, Jakafi, Pemazyre |
| Beigene USA, INC. | $332.41 | 2020-2025 | Brukinsa |
| Glaxosmithkline, LLC. | $331.50 | 2020-2025 | Ojjaara, Jemperli, Zejula |
| Abbvie INC. | $313.15 | 2019-2025 | Venclexta |
| Octapharma USA, INC. | $302.78 | 2020-2021 | |
| Lilly USA, LLC | $298.40 | 2019-2025 | Jaypirca, Verzenio, Retevmo |
| Takeda Pharmaceuticals U.S.A., INC. | $268.14 | 2019-2025 | Ninlaro, Fruzaqla, Iclusig |
| Astellas Pharma US INC | $253.64 | 2019-2025 | Vyloy, Xospata, Padcev |
| Blueprint Medicines Corporation | $233.61 | 2020-2022 | |
| Gilead Sciences, INC. | $218.69 | 2019-2025 | Trodelvy |
| Pharmacyclics LLC, An Abbvie Company | $210.05 | 2020-2023 | Imbruvica |
| Array Biopharma INC | $200.40 | 2021-2025 | Braftovi, Mektovi, Lorbrena |
| Aveo Pharmaceuticals, INC. | $185.02 | 2021-2025 | Fotivda |
| Celltrion USA INC. | $182.46 | 2025 | Vegzelma |
| Bayer Healthcare Pharmaceuticals INC. | $152.64 | 2019-2025 | |
| Jazz Pharmaceuticals INC. | $133.30 | 2020-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $131.70 | 2019-2025 | Gilotrif |
| Foundation Medicine, INC. | $128.96 | 2019-2020 | |
| Exelixis INC. | $127.69 | 2019-2023 | Cabometyx |
| Emd Serono, INC. | $126.64 | 2021-2025 | |
| Seagen INC. | $123.01 | 2020-2023 | Padcev, Adcetris, Tivdak |
| Karyopharm Therapeutics INC. | $118.55 | 2021-2023 | Xpovio |
| Beone Medicines USA, INC. | $104.52 | 2025 | Brukinsa, Tevimbra |
| Coherus Oncology, INC. | $103.59 | 2020-2024 | |
| Puma Biotechnology, INC. | $103.39 | 2019-2024 | Nerlynx |
| Taiho Oncology, INC. | $86.94 | 2019-2025 | |
| Apellis Pharmaceuticals, INC. | $82.09 | 2023-2025 | Empaveli |
| Pharmacosmos Therapeutics INC. | $77.02 | 2021-2025 | Monoferric, Cosela |
| Progenics Pharmaceuticals, INC. | $75.79 | 2021-2024 | Pylarify |
| Springworks Therapeutics, INC. | $71.19 | 2024-2025 | Ogsiveo |
| Dendreon Pharmaceuticals LLC | $69.41 | 2019-2020 | |
| Rigel Pharmaceuticals, INC. | $67.49 | 2019-2024 | Tavalisse, Rezlidhia |
| Global Blood Therapeutics, INC. | $66.41 | 2020-2022 | |
| Deciphera Pharmaceuticals INC. | $65.27 | 2021-2022 | |
| Mirati Therapeutics, INC. | $63.23 | 2023-2024 | Krazati |
| Janssen Pharmaceuticals, INC | $59.79 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $59.17 | 2019-2020 | |
| G1 Therapeutics, INC. | $55.05 | 2022-2023 | Cosela |
| Myriad Genetic Laboratories, INC. | $53.10 | 2021-2024 | Myrisk |
| Pharmaessentia USA Corporation | $52.99 | 2025 | Besremi |
| Immunocore Limited | $52.93 | 2024-2025 | Kimmtrak |
| Tersera Therapeutics LLC | $52.15 | 2021-2024 | Quzyttir |
| Acceleron Pharma, INC. | $49.24 | 2021 | |
| Kyowa Kirin, INC. | $47.25 | 2019-2025 | |
| Csl Behring | $40.61 | 2021-2023 | Afstyla, Idelvion |
| Kite Pharma, INC. | $38.30 | 2021-2023 | |
| Alexion Pharmaceuticals, INC. | $38.22 | 2023-2024 | Ultomiris |
| Secura Bio, INC. | $36.33 | 2020-2021 | |
| Agios Pharmaceuticals, INC. | $36.19 | 2023-2025 | Pyrukynd |
| Novocure INC. | $36.09 | 2021-2025 | Optune Lua (Novottf-200t) |
| Aurobindo Pharma USA, INC. | $30.74 | 2020 | |
| Lexicon Pharmaceuticals, INC. | $30.44 | 2019-2020 | |
| Dova Pharmaceuticals | $29.83 | 2020 | |
| Heron Therapeutics, INC. | $27.22 | 2022 | |
| Adaptive Biotechnologies Corporation | $26.23 | 2022-2023 | Clonoseq |
| Syndax Pharmaceuticals, INC. | $25.12 | 2025 | |
| Clovis Oncology, INC. | $24.63 | 2019 | |
| Geron Corporation | $23.36 | 2025 | Rytelo |
| Emmaus Medical, INC. | $23.15 | 2020 | |
| Amag Pharmaceuticals, INC. | $22.70 | 2021 | |
| Sun Pharmaceutical Industries INC. | $21.20 | 2023 | Odomzo, Yonsa |
| Sobi, INC | $18.29 | 2023 | |
| Genmab U.S., INC. | $18.11 | 2023 | Epkinly |
| Spectrum Pharmaceuticals INC. | $16.95 | 2023 | Rolvedon |
| Tg Therapeutics, INC. | $16.93 | 2022 | |
| Acrotech Biopharma INC. | $16.42 | 2023 | Beleodaq |
| Servier Pharmaceuticals LLC | $15.13 | 2022 | |
| Helsinn Therapeutics (U.S.), INC. | $15.12 | 2021 | |
| Alnylam Pharmaceuticals INC. | $14.85 | 2021 | |
| Sumitomo Pharma America, INC. | $13.75 | 2023 | Orgovyx |
| Tesaro, INC. | $13.66 | 2019 | |
| Morphosys, US INC. | $13.38 | 2022 | |
| Adc Therapeutics America, INC. | $13.11 | 2022 | |
| Epizyme, INC. | $11.50 | 2021 | |
| Verastem, INC. | $11.40 | 2020 |
Drugs and devices associated with these payments
Libtayo $648Reblozyl $586Elzonris $503Opdivo $416Keytruda $410Enhertu $400Kisqali $285Brukinsa $257Lynparza $218Onivyde $195Lenvima $189Vegzelma $182Imbruvica $180Sarclisa $179Pluvicto $171Scemblix $167Imfinzi $164Polivy $159Verzenio $153Jaypirca $153Darzalex $150Somatuline Depot $149Tecvayli $144Padcev $142Braftovi $131Ninlaro $127Monjuvi $123Fotivda $121Pomalyst $120Lunsumio $118Mektovi $110Calquence $110Fabhalta $107Columvi $103Krazati $102Retevmo $97.54Talvey $96.59Ojjaara $92.25Orserdu $89.82Erleada $89.31Jakafi $86.55Empaveli $82.09Venclexta $81.91Opdualag $78.75Tasigna $76.12Piqray $74.27Lutathera $73.45Stivarga $73.18Vitrakvi $73.18Ogsiveo $71.19Mekinist $70.59Xpovio $70.31Udenyca $67.70Zepzelca $67.63Pylarify $61.89Lorbrena $60.37Pemazyre $59.90Trodelvy $57.83Cosela $57.78Promacta $56.44Epkinly $53.46Besremi $52.99Kimmtrak $52.93Carvykti $52.05Datroway $51.93Vyloy $51.86Elahere $51.46Tukysa $49.84Monoferric $44.25Balversa $44.21Akeega $44.21Nubeqa $41.93Xalkori $41.51Tevimbra $40.66Jemperli $39.54Ultomiris $38.22Xospata $37.02Oxbryta $36.82Adcetris $33.75Rezlidhia $33.57Tavalisse $33.57Tecentriq $32.36Ibrance $30.65Myrisk $29.54Elrexfio $29.15Bosulif $29.15Rybrevant $28.95Fruzaqla $26.66Quzyttir $26.23Idelvion $25.33Afstyla $25.33Xofigo $24.85Keytruda Qlex $24.70Welireg $24.29Inqovi $23.62Lonsurf $23.62Rytelo $23.36Elitek $22.89Jevtana $22.60Gilotrif $21.86
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Weber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.